Logo

American Heart Association

  30
  0


Final ID:

Reducing plasma triglyceride levels via apolipoprotein C-III inhibition

  • Tsimikas, Sotirios  ( University of California, San Diego , Rancho Santa Fe , California , United States )
  • Watts, Gerald  ( University of Western Australia , Perth , Western Australia , Australia )
  • Author Disclosures:
    Sotirios Tsimikas: DO have relevant financial relationships ; Royalties/Patent Beneficiary:UCSd:Active (exists now) ; Employee:Ionis:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Ownership Interest:Oxitope:Active (exists now) ; Ownership Interest:Kleanthi:Active (exists now) | Gerald Watts: DO have relevant financial relationships ; Consultant:A:Active (exists now) ; Consultant:Sanofi-Regeneron:Active (exists now) ; Consultant:CSL Seqirus:Active (exists now) ; Consultant:Silence Therapeutics:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Pfizer:Active (exists now) ; Consultant:Astra Zeneca:Active (exists now) ; Consultant:Esperion:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Consultant:Amgen:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Triglyceride-Rich Lipoproteins in Cardiovascular and Metabolic Disease

Friday, 11/07/2025 , 12:30PM - 01:45PM

Cardiovascular Seminar

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available